Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 3Not yet recruiting 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 47Carcinoma, Hepatocellular 9Triple Negative Breast Neoplasms 7Stomach Neoplasms 6Inflammatory Breast Neoplasms 6Lymphoma, Large B-Cell, Diffuse 4Urinary Bladder Neoplasms 3Non-Muscle Invasive Bladder Neoplasms 3Esophageal Neoplasms 3Recurrence 2Lymphoma 2Breast Neoplasms, Male 2Breast Diseases 2Upper Tract Urothelial Carcinoma 1Thymoma 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Pancreatic Neoplasms 1Oesophagogastric Cancer 1Neoplastic Cells, Circulating 1Neoplasms, Unknown Primary 1Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lung Neoplasms 1Liver Neoplasms 1Leiomyosarcoma 1

Interventions

Epirubicin 3Gemcitabine 2tislelizumab 1lornoxicam 1catumaxomab 1avelumab 1apatorsen 1VB4-845 1Ty21a typhoid vaccine 1Therapeutics 1Radiotherapy 1Postoperative Period 1Ofloxacin 1Multiparametric Magnetic Resonance Imaging 1Mitomycin 1Docetaxel 1Cystoscopy 1BCG Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Non-Muscle Invasive Bladder Neoplasms × Epirubicin × Clear all
NCT05547516 2022-09-21

BL-PDT-RCT

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Unknown
140 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT04490993 2022-02-22

ACCRUE

Jiangsu Yahong Meditech Co., Ltd aka Asieris

Phase 3 Unknown
359 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT04736394 2022-02-22

ASCERTAIN

Jiangsu Yahong Meditech Co., Ltd aka Asieris

Phase 3 Unknown
800 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡